Cite
MLA Citation
Eva Kimby et al.. “Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas.” Leukemia & lymphoma, vol. 56, no. 9, n.d., pp. 2598–2607. http://access.bl.uk/ark:/81055/vdc_100089569274.0x000035